{"nctId":"NCT03945357","briefTitle":"Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)","startDateStruct":{"date":"2019-05-15","type":"ACTUAL"},"conditions":["Ventral Hernia Repair"],"count":250,"armGroups":[{"label":"Saline Irrigation","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Normal saline"]},{"label":"Antibiotic Irrigation","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Gemcitabine/ clindamycin"]}],"interventions":[{"name":"Gemcitabine/ clindamycin","otherNames":[]},{"name":"Normal saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\>18 y/o.\n* Elective, open ventral hernia repair in a retromuscular fashion, with or without TAR.\n* Clean, clean-contaminated, or contaminated wounds.\n\nExclusion Criteria:\n\n* Age \\<18 y/o.\n* Pregnancy.\n* Emergency hernia repair.\n* Laparoscopic, robotic, or hybrid approach.\n* Dirty wounds.\n* Use of biologic or absorbable synthetic mesh.\n* Onlay, intraperitoneal or preperitoneal mesh placement.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Surgical Site Infection","description":"Number of participants with Surgical Site Infections","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of SSI Requiring Intervention","description":"Number of participants with SSI requiring reoperation or other procedural intervention at 30 days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":124},"commonTop":["ileus"]}}}